Zydus receives Mexican regulatory approval for cancer drug - Bhava 0 22.07.2024 06:39 Business Standard Zydus Lifesciencesannounced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava™, a Bevacizumab biosimilar. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
